Tag: pharmaceutical lobbying
Getting spending on Social Security, Medicare, and Medicaid “under control” is at the top of all the budgeteers’ agenda. While the intention sounds reasonable, spending on these programs is not out of control. Social Security spending is slated to rise from roughly 5 percent of GDP to 6 percent of GDP between 2023 and…